跳至主要内容
临床试验/NCT00722189
NCT00722189已完成不适用

Observational Study of the Efficacy, Safety and Tolerance of Travogen Cream (Isoconazole) and Travocort Cream (Isoconazole, Diflurcortolone) in the Treatment of Patients With Local Skin Mycosis of Various Etiology and Localization

LEO Pharma1 个研究点 分布在 1 个国家目标入组 900 人开始时间: 2008年7月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
LEO Pharma
入组人数
900
试验地点
1
主要终点
Efficacy of Travogen / Travocort in the treatment of skin mycoses / Travogen Cream and Travocort Cream will be prescribed by a physician

研究概览

简要总结

An assessment of the efficacy and safety of Travogen cream and Travocort cream in the treatment of local skin mycoses

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Diagnosis of skin mycosis

排除标准

  • Allergies to study medication

结局指标

主要结局

Efficacy of Travogen / Travocort in the treatment of skin mycoses / Travogen Cream and Travocort Cream will be prescribed by a physician

时间窗: Baseline to end of study

次要结局

  • Patient satisfaction(Baseline to end of study)

研究者

发起方
LEO Pharma
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Observational Study of Efficacy and Safety of... | 临床试验